BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3569488)

  • 1. Inactivation of sarin and soman by cyclodextrins in vitro.
    Désiré B; Saint-André S
    Experientia; 1987 Apr; 43(4):395-7. PubMed ID: 3569488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of soman with beta-cyclodextrin.
    Desire B; Saint-Andre S
    Fundam Appl Toxicol; 1986 Nov; 7(4):646-57. PubMed ID: 3803759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit.
    Koplovitz I; Stewart JR
    Toxicol Lett; 1994 Feb; 70(3):269-79. PubMed ID: 8284794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of memantine, D-tubocurarine, and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX.
    Gupta RC; Dettbarn WD
    Neurotoxicology; 1992; 13(3):649-61. PubMed ID: 1475066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inactivation of soman by beta-cyclodextrin].
    Saint-André S; Désiré B
    C R Acad Sci III; 1985; 301(3):67-72. PubMed ID: 3930009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
    Harris LW; Talbot BG; Lennox WJ; Anderson DR; Solana RP
    Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H; Tsuruoka M; Hashimoto T; Fujinaga T; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes.
    Ohtani Y; Irie T; Uekama K; Fukunaga K; Pitha J
    Eur J Biochem; 1989 Dec; 186(1-2):17-22. PubMed ID: 2598927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of an oximate-based skin decontaminant against organophosphate nerve agents determined in vivo and in vitro.
    Sawyer TW; Parker D; Thomas N; Weiss MT; Bide RW
    Toxicology; 1991 May; 67(3):267-77. PubMed ID: 2048130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemical analysis of the nerve agents soman, sarin, tabun, and VX by proton NMR-spectroscopy with optically active shift reagents.
    Van den Berg GR; Beck HC; Benschop HP
    Bull Environ Contam Toxicol; 1984 Nov; 33(5):505-14. PubMed ID: 6498353
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of beta-cyclodextrin on the degradation rate of cinnarizine in aqueous solution.
    Tokumura T; Tatsuishi K; Kayano M; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2079-83. PubMed ID: 4053231
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase.
    Esposito EX; Stouch TR; Wymore T; Madura JD
    Chem Res Toxicol; 2014 Jan; 27(1):99-110. PubMed ID: 24443939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay.
    Wille T; Tenberken O; Reiter G; Müller S; Le Provost R; Lafont O; Estour F; Thiermann H; Worek F
    Toxicology; 2009 Nov; 265(3):96-100. PubMed ID: 19800384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of pharmacological activity of CERM 3726 with a ground mixture of beta-cyclodextrin in mice.
    Luu SN; Chaperon F; Leinot M; Pourrat A
    Pharm Acta Helv; 1987; 62(12):335-6. PubMed ID: 3441478
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes.
    Uekama K; Uemura Y; Irie T; Otagiri M
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3637-43. PubMed ID: 6671224
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of tri-O-methyl-beta-cyclodextrin with drugs. II. Enhanced bioavailability of ketoprofen in rats when administered with tri-O-methyl-beta-cyclodextrin.
    Nakai Y; Yamamoto K; Terada K; Horibe H; Ozawa K
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3745-7. PubMed ID: 6671012
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of beta-cyclodextrin on sleeping time induced by barbituric acid derivatives in mice.
    Shirakura O; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3517-21. PubMed ID: 4085080
    [No Abstract]   [Full Text] [Related]  

  • 19. Soman and sarin induce a long-lasting naloxone-reversible analgesia in mice.
    Clement JG; Copeman HT
    Life Sci; 1984 Apr; 34(15):1415-22. PubMed ID: 6708739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP).
    Little JS; Broomfield CA; Fox-Talbot MK; Boucher LJ; MacIver B; Lenz DE
    Biochem Pharmacol; 1989 Jan; 38(1):23-9. PubMed ID: 2910306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.